Literature DB >> 21988990

Epigenetic tumor suppression by BRCA1.

Aneliya Velkova, Alvaro N A Monteiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21988990     DOI： 10.1038/nm.2493

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155.

Authors:  Suhwan Chang; Rui-Hong Wang; Keiko Akagi; Kyung-Ae Kim; Betty K Martin; Luca Cavallone; Diana C Haines; Mark Basik; Phuong Mai; Elizabeth Poggi; Claudine Isaacs; Lai M Looi; Kein S Mun; Mark H Greene; Stephen W Byers; Soo H Teo; Chu-Xia Deng; Shyam K Sharan
Journal:  Nat Med       Date:  2011-09-25       Impact factor: 53.440

2.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

3.  Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.

Authors:  Megan S Lee; Ruth Green; Sylvia M Marsillac; Nicolas Coquelle; R Scott Williams; Telford Yeung; Desmond Foo; D Duong Hau; Ben Hui; Alvaro N A Monteiro; J N Mark Glover
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

4.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 5.  BRCA1 and BRCA2: 1994 and beyond.

Authors:  Steven A Narod; William D Foulkes
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

6.  Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

Authors:  Deann P Atchley; Constance T Albarracin; Adriana Lopez; Vicente Valero; Christopher I Amos; Ana Maria Gonzalez-Angulo; Gabriel N Hortobagyi; Banu K Arun
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

7.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.

Authors:  Stefan Costinean; Sukhinder K Sandhu; Irene M Pedersen; Esmerina Tili; Rossana Trotta; Danilo Perrotti; David Ciarlariello; Paolo Neviani; Jason Harb; Lauren Rachel Kauffman; Aaditya Shidham; Carlo Maria Croce
Journal:  Blood       Date:  2009-06-11       Impact factor: 22.113

8.  Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.

Authors:  Joanna R Morris; Laurent Pangon; Chris Boutell; Toyomasa Katagiri; Nicholas H Keep; Ellen Solomon
Journal:  Hum Mol Genet       Date:  2006-01-10       Impact factor: 6.150

9.  Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

Authors:  Paul K Lovelock; Amanda B Spurdle; Myth T S Mok; Daniel J Farrugia; Sunil R Lakhani; Sue Healey; Stephen Arnold; Daniel Buchanan; Fergus J Couch; Beric R Henderson; David E Goldgar; Sean V Tavtigian; Georgia Chenevix-Trench; Melissa A Brown
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; Mark P Boldin; Konstantin D Taganov; John Nicoll; Ronald L Paquette; David Baltimore
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307
  10 in total
  2 in total

Review 1.  A guide for functional analysis of BRCA1 variants of uncertain significance.

Authors:  Gaël A Millot; Marcelo A Carvalho; Sandrine M Caputo; Maaike P G Vreeswijk; Melissa A Brown; Michelle Webb; Etienne Rouleau; Susan L Neuhausen; Thomas v O Hansen; Alvaro Galli; Rita D Brandão; Marinus J Blok; Aneliya Velkova; Fergus J Couch; Alvaro N A Monteiro
Journal:  Hum Mutat       Date:  2012-07-16       Impact factor: 4.878

Review 2.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.